「他人の不幸は金になる$♡」コロナ禍、世界中で大富豪が急増。

41415768-9440573-image-m-37_1617736989935
世界長者番付、首位は今年もベゾス コロナ禍で富豪が急増
フォーブスは4月6日、今年で35回目となる毎年恒例の「世界長者番付」を発表した。新型コロナウイルスのパンデミックが経済大国を含め各国に多大な影響を及ぼすなか、ビリオネア(保有資産10億ドル以上)の数は過去最多を更新。2755人となった。うち493人が初のリスト入りとなっている。
今年の番付に入った富豪たちが保有する資産は、合計およそ13兆1000億ドル(約1445兆円)。昨年の約8兆ドルから大幅に増加した。
詳細↓

ワクチン開発、検査キット、マスク、防護具…
コロナ関連事業で大富豪の仲間入りを果たしたCEO40名の内、14名は中国人および中華系

1. Li Jianquan & family (Hong Kong) – $6.8 Billion; Winner Medical Consumer products

2. Stéphane Bancel (France) – $4.3 Billion; CEO of Moderna Moderna

3. Liu Fangyi (China) – $4.2 Billion; founder and chairman of Intco Medical

4. Uğur Şahin (Germany) – $4 Billion; CEO & Co-founder of BioNTech

5. Yuan Liping (Canada) – $3.6 Billion; 24% stake in Shenzhen Kangtai Biological Products – Pharmaceuticals

6. Hu Kun (China) – $2.5 Billion; Contec Medical Systems – Medical equipment

7. Chen Xiao Ying (China) – $2.4 Billion; Investor in Alibaba Health Information Technology – Health Information

8. Dai Lizhong (China) $2.4 Billion; Chariman of Sansure Biotech – Medical testing

9. Karin Sartorius-Herbst (Germany) – $2.4 Billion; Stake in Sartorius group, pharmaceutical & laboratory equipment supplier – Bio-pharmaceuticals

10. Ulrike Baro (Germany) – $1.5 Billion; Stake in Sartorius group – bio-pharmaceuticals

11. Timothy Springer (United States) – $2.2 Billion; Professor & founding investor in Moderna, 3.5% stake – Biotech

12. Gong Yingying (China) – $2.1 Billion; Founder & chairwoman of Yidu Tech – Health IT

13. Weng Xianding (China) – $2.1 Billion; Majority shareholder, Shenzhen New Industries Biological Engineering – Medical devices

14. Rao Wei & family (China) – $1.2 Billion; Chairman, Shenzhen New Industries Biological Engineering – Pharmaceuticals

15. Sergio Stevanato (Italy) – $1.9 Billion; Majority owner & chairman, Stevanato Group – Medical Packaging

16. Noubar Afeyan (United States) – $1.9 Billion; Chairman & co-founder of Moderna – Biotech

17. Carl Hansen (Canada) – $1.8 Billion; Founder & CEO of Canadian biotech firm AbCellera – Biotech

18. Juan López-Belmonte López & family (Spain) – $1.8 Billion; Chairs Spanish pharma company Rovi – Pharmaceuticals

19. John Oyler (United States) – $1.8 Billion; CEO & co-founder of Beijing-based drugmaker BeiGene – Biotech

20. Robert Langer (United States) – $1.6 Billion; 3% stake in Moderna, helped start in 2010 – Biotech

21. Ren Jinsheng & family (China) – $1.5 Billion; Founder & chairman of Simcere Pharmaceutical Group – Pharmaceuticals

22. Arvind Lal (India) – $1.5 Billion; Executive chairman of Indian diagnostics chain Dr. Lal PathLabs – Medical Diagnostics

23. Prathap Reddy (India) – $1.5 Billion; Founder & chairman of Indian hospital chain Apollo Hospitals Group – Healthcare

24. August Troendle (United States) – $1.5 Billion; CEO & founder of Cincinnati-based contract research firm Medpace – Pharmaceutical Services

25. Liang Yaoming (China( – $1.4 Billion; Chair of testing company Guangzhou Kingmed Diagnostics Group – Diagnostics

26. Itaru Tanimura (Japan) – $1.4 Billion; Founder of Tokyo-based online medical services provider M3 – Healthcare

27. Keith Dunleavy & family (United States) – $1.4 Billion; Founder of cloud-based healthcare data analytics outfit Inovalon – Health IT

28. Alan Miller & family (United States) – $1.3 Billion; Founder & executive chairman of healthcare services provider Universal Health Services – Healthcare services

29. Cao Xiaochun (China) – $1.3 Billion; Cofounder & director of pharmaceutical contract research outfit Hangzhou Tigermed Consultin – Pharmaceuticals

30. Xiong Jun & family (China) – $1.3 Billion; Chair bio-pharma company Shanghai Junshi Biosciences – Pharmaceuticals

31. Zhu Tao (China) – $1.3 Billion; Cofounder of Tianjin-based vaccine manufacturer CanSino Biologics – Pharmaceuticals

32. Qiu Dongxu (Canada) – $1.2 Billion; Cofounder of Tianjin-based vaccine manufacturer CanSino Biologics – Pharmaceuticals

33. Yu Xuefeng (Canada) – $1.2 Billion; Cofounder of Tianjin-based vaccine manufacturer CanSino Biologics – Pharmaceuticals

34. Mao Huihua (Canada) – $1 Billion; Cofounder of Tianjin-based vaccine manufacturer CanSino Biologics – Pharmaceuticals

35. Premchand Godha (India) – $1.2 Billion; Chair of Mumbai-based generic drug manufacturer Ipca Labs – Pharmaceuticals

36. Feng Yuxia (China) – $1.1 Billion; President of Beijing-based contract research organization JOINN Laboratories – Pharmaceuticals

37. Li Wenmei & family (China) – $1.1 Billion; Co-founder & general manager of diagnostic test supplier Guangzhou Wondfo Biotech – Medical equipment

38. M.Satyanarayana Reddy (India) – $1.1 Billion; Founder & chairman of Hyderabad-based drugmaker MSN Group – Pharmaceuticals

39. Jack Schuler (United States) – $1.1 Billion; 7% stake in diagnostic firm Quidel Corp – Pharmaceuticals

40. Yu De-Chao (United States) – $1 Billion; Cofounder & chairman of Chinese biopharma outfit Innovent Biologics – Pharmaceuticals

続きを読む

「日本が処理水の海洋放出決定←もう認めてあげるしかないよな?」

no title
原発処理水、海洋放出決定へ 政府、13日にも閣僚会議 東電福島第1、漁業者反発

政府は9日、東京電力福島第1原発から出る放射性物質トリチウムを含む処理水の処分方法に関し、海洋放出とする方針を固めた。
処理水を人体に影響がないレベルまで薄めて徐々に放出する方針。
漁業関係者らは周辺海域の水産物に対する風評被害を強く懸念しており、政府は安全面の周知をはじめとする対策に全力を挙げる考えだ。

詳細↓

続きを読む